Jade Clarson

416 total citations
9 papers, 299 citations indexed

About

Jade Clarson is a scholar working on Hematology, Immunology and Genetics. According to data from OpenAlex, Jade Clarson has authored 9 papers receiving a total of 299 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hematology, 7 papers in Immunology and 5 papers in Genetics. Recurrent topics in Jade Clarson's work include Chronic Myeloid Leukemia Treatments (7 papers), Immune Cell Function and Interaction (6 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Jade Clarson is often cited by papers focused on Chronic Myeloid Leukemia Treatments (7 papers), Immune Cell Function and Interaction (6 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Jade Clarson collaborates with scholars based in Australia, Germany and Switzerland. Jade Clarson's co-authors include Agnes S. M. Yong, Timothy P. Hughes, Deborah L. White, Amy Hughes, David M. Ross, Amy Hughes, Chung Hoow Kok, David T Yeung, Yazad Irani and Naranie Shanmuganathan and has published in prestigious journals such as Nature Communications, Blood and British Journal of Haematology.

In The Last Decade

Jade Clarson

9 papers receiving 298 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jade Clarson Australia 6 197 122 120 106 55 9 299
Tiina Hannunen Finland 4 50 0.3× 139 1.1× 56 0.5× 125 1.2× 19 0.3× 4 285
Shady Adnan Awad Finland 11 174 0.9× 65 0.5× 124 1.0× 60 0.6× 46 0.8× 23 299
Bárbara da Costa Reis Monte-Mór Brazil 8 172 0.9× 49 0.4× 144 1.2× 27 0.3× 33 0.6× 19 367
Daniel Egan United States 8 127 0.6× 123 1.0× 33 0.3× 49 0.5× 11 0.2× 22 212
Jennifer Cassels United Kingdom 7 166 0.8× 43 0.4× 94 0.8× 42 0.4× 39 0.7× 17 250
Sally‐Ann Clark United Kingdom 6 137 0.7× 35 0.3× 84 0.7× 62 0.6× 36 0.7× 9 326
Frank Osterroth Germany 8 69 0.4× 114 0.9× 30 0.3× 135 1.3× 9 0.2× 11 250
Marina Motta Italy 9 52 0.3× 64 0.5× 145 1.2× 126 1.2× 7 0.1× 25 264
Hélène Guermouche France 8 59 0.3× 50 0.4× 44 0.4× 39 0.4× 22 0.4× 12 170
Wenhong Shen China 4 83 0.4× 332 2.7× 31 0.3× 302 2.8× 21 0.4× 10 416

Countries citing papers authored by Jade Clarson

Since Specialization
Citations

This map shows the geographic impact of Jade Clarson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jade Clarson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jade Clarson more than expected).

Fields of papers citing papers by Jade Clarson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jade Clarson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jade Clarson. The network helps show where Jade Clarson may publish in the future.

Co-authorship network of co-authors of Jade Clarson

This figure shows the co-authorship network connecting the top 25 collaborators of Jade Clarson. A scholar is included among the top collaborators of Jade Clarson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jade Clarson. Jade Clarson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Kok, Chung Hoow, Yazad Irani, Jade Clarson, et al.. (2024). CD302 predicts achievement of deep molecular response in patients with chronic myeloid leukemia treated with imatinib. PubMed. 1(2). 100014–100014. 1 indexed citations
2.
Irani, Yazad, Chung Hoow Kok, Jade Clarson, et al.. (2023). Association of TIM-3 checkpoint receptor expression on T cells with treatment-free remission in chronic myeloid leukemia. Blood Advances. 7(11). 2364–2374. 14 indexed citations
3.
Irani, Yazad, Amy Hughes, Chung Hoow Kok, et al.. (2023). Immune modulation in chronic myeloid leukaemia patients treated with nilotinib and interferon‐alpha. British Journal of Haematology. 202(6). 1127–1136. 5 indexed citations
4.
Hughes, Amy, Wenbo Yu, Renier Myburgh, et al.. (2021). Demethylating therapy increases anti-CD123 CAR T cell cytotoxicity against acute myeloid leukemia. Nature Communications. 12(1). 6436–6436. 76 indexed citations
5.
Irani, Yazad, Amy Hughes, Jade Clarson, et al.. (2020). Successful treatment‐free remission in chronic myeloid leukaemia and its association with reduced immune suppressors and increased natural killer cells. British Journal of Haematology. 191(3). 433–441. 54 indexed citations
6.
Hughes, Amy, Wenbo Yu, Sanaz Taromi, et al.. (2019). Azacytidine Sensitizes AML Cells for Effective Elimination By CD123 CAR T-Cells. Blood. 134(Supplement_1). 3904–3904. 4 indexed citations
7.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026